Citadel Advisors’s GT Biopharma GTBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27K Sell
66,165
-14,596
-18% -$7.96K ﹤0.01% 12604
2025
Q4
$63.4K Buy
80,761
+41,128
+104% +$29.2K ﹤0.01% 11918
2025
Q3
$23.6K Buy
+39,633
New +$59.2K ﹤0.01% 12461
2025
Q2
Sell
-20,138
Closed -$45.1K 13588
2025
Q1
$45.1K Buy
+20,138
New +$47.4K ﹤0.01% 12412
2024
Q1
Sell
-1,927
Closed -$14.7K 14945
2023
Q4
$14.7K Buy
+1,927
New +$14.1K ﹤0.01% 12864
2023
Q2
Sell
-1,239
Closed -$20.4K 14724
2023
Q1
$20.4K Buy
+1,239
New +$28.4K ﹤0.01% 13052
2022
Q3
Sell
-2,033
Closed -$182K 13105
2022
Q2
$182K Buy
2,033
+466
+30% +$35.3K ﹤0.01% 10804
2022
Q1
$135K Buy
1,567
+1,186
+311% +$105K ﹤0.01% 11967
2021
Q4
$35K Sell
381
-90
-19% -$13.5K ﹤0.01% 13414
2021
Q3
$95K Sell
471
-16,531
-97% -$4.98M ﹤0.01% 12938
2021
Q2
$7.91M Buy
+17,002
New +$7.06M 0.01% 3518

Other funds holding GTBP